申请人:Hoechst Aktiengesellschaft
公开号:US05811448A1
公开(公告)日:1998-09-22
Substituted chromanylsulfonyl(thio)ureas, processes for their preparation, their use in pharmaceutical preparations, and pharmaceutical preparations comprising them Chromanylsulfonyl(thio)ureas of the formula I ##STR1## are useful pharmaceuticals for the treatment of cardiac arrhythmias and for the prevention of sudden heart death due to arrhythmia. They can be used as antiarrhythmics and are suitable for the prevention of sudden heart death, for the treatment of cardiac insufficiency and also heart failure as a result of the effects of shock.
取代的氨基(硫)脲基苯磺酰,其制备方法,其在制药制剂中的应用,以及包含它们的制药制剂。 具有以下结构的氨基(硫)脲基苯磺酰化合物是治疗心律失常和预防心律失常导致的突发心脏死亡的有效药物。 它们可用作抗心律失常药物,适用于预防突发心脏死亡,治疗心脏功能不全,以及由休克影响引起的心力衰竭。